RxDoctor Payments DataLook up a doctor →

Theron McCormick

Pediatric Allergy/Immunology · Baton Rouge, LANPI 1649367541

Payments from drug & device makers

$52,179in general payments, 2019–2025

Across 673 payments — averaging $77.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$25K
  • Ionis Pharmaceuticals, Inc.$13K
  • AstraZeneca$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Pfizer$1K
  • plus $8K from 34 others

What the payments were for

  • Consulting fees$4,4268%
  • Speaking & faculty fees$27,02352%
  • Travel & lodging$5,09610%
  • Food & beverage$15,19029%
  • Education$4451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring102$25,497
Ionis Pharmaceuticals, Inc.25$13,188
AstraZeneca61$1,617
Regeneron Healthcare Solutions, Inc.59$1,488
Takeda Pharmaceuticals U.S.A., Inc.22$1,403
Pfizer71$1,357
Sanofi34$1,115
GSK59$1,063
Genentech USA, Inc.36$1,033
Novartis30$595
Amgen(2 entities)30$568
Grifols USA, LLC20$435
Biocryst US Sales Co., LLC17$394
Galderma Laboratories, L.p.16$328
Incyte Corporation9$257
ARS Pharmaceuticals Operations, Inc.5$231
Pharming Healthcare, Inc.9$175
Sanofi-aventis U.S. LLC4$167
Lilly USA, LLC2$146
Alk-abello, Inc6$114
Merck6$110
Medtronic6$97
Organon6$97
Optinose US, Inc.6$83
Baxter Healthcare2$63
ADMA Biomanufacturing LLC2$59
USWM, LLC2$53
Aytu Biopharma, Inc.3$50
Octapharma USA, Inc.2$49
Kaleo, Inc.3$49
LEO Pharma Inc.3$47
Biocryst Pharmaceuticals, Inc.3$46
Phadia US Inc.2$37
Teva Pharmaceuticals USA, Inc.2$33
Shire North American Group Inc2$33
Greer Laboratories, Inc.2$29
Cipher Pharmaceuticals US LLC1$20
Aimmune Therapeutics, Inc.1$18
Tersera Therapeutics LLC1$17
Jubilant Hollisterstier LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HaegardaC1 Esterase Inhibitor11$787,344
Ipratropium Bromide14$586
Azelastine Hcl11$277
Fluticasone Propionate20$244

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringHaegarda$25,497$787,34411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric allergy/immunology providers in Louisianaon file to place this against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Baton Rouge

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →